Invoke Bio

Invoke Bio offers fellows the opportunity to work on AI-driven personalized cancer immunotherapy. Fellows will gain experience with machine learning models that integrate multifaceted biomolecular signals to predict tumor-specific immune targets, with systems deployed in clinical settings including Stanford Medicine and UC San Diego. Backed by Pear VC, NFX, HCVC, and Incite.